Mostrar el registro sencillo del ítem
dc.contributor.author | Palau González, Vanesa |
dc.contributor.author | Riera, Marta |
dc.contributor.author | Soler, María José |
dc.date.accessioned | 2021-10-26T05:58:25Z |
dc.date.available | 2021-10-26T05:58:25Z |
dc.date.issued | 2020 |
dc.identifier.citation | Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol Dial Transplant. 2020;35(6):1071-2. DOI: 10.1093/ndt/gfaa093 |
dc.identifier.issn | 0931-0509 |
dc.identifier.uri | http://hdl.handle.net/10230/48810 |
dc.format.mimetype | application/pdf |
dc.language.iso | eng |
dc.publisher | Oxford University Press |
dc.relation.ispartof | Nephrol Dial Transplant. 2020;35(6):1071-2 |
dc.rights | © Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Nephrology, dialysis, transplantation following peer review. The version of record Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol Dial Transplant. 2020;35(6):1071-2. DOI: 10.1093/ndt/gfaa093 is available online at: http://dx.doi.org/10.1093/ndt/gfaa093 |
dc.title | ADAM17 inhibition may exert a protective effect on COVID-19 |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | http://dx.doi.org/10.1093/ndt/gfaa093 |
dc.subject.keyword | covid-19 |
dc.rights.accessRights | info:eu-repo/semantics/openAccess |
dc.type.version | info:eu-repo/semantics/acceptedVersion |